New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Women emerge as the cornerstone of this monumental undertaking
The facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
The facility will accommodate over 1,500 employees
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
The agreement sets terms under which POC will manufacture the product or receive royalties
Subscribe To Our Newsletter & Stay Updated
